Canadian panel recommends AstraZeneca vaccination pause for under 55

Canada’s National Advisory Committee on Immunization is recommending a pause on AstraZeneca COVID-19 vaccinations for people under 55 for safety reasons, a person familiar with the matter tells The Associated Press.

The person confirms the recommendation on condition of anonymity as they are not authorized to speak publicly before the announcement. It remains a recommendation and it is up to each of Canada’s provinces to decide to follow it or not.

It is not immediately clear why that is being recommended, but several European countries that have suspended using the vaccine over concerns it could cause blood clots have resumed administering it after the EU’s drug regulator said the vaccine was safe.

Canada is expected to receive 1.5 million does of AstraZeneca from the US this week.

The vaccine is used widely in Britain, across the European continent and in other countries, but its rollout was troubled by inconsistent study reports about its effectiveness, and then more recently a scare about clots that had some countries temporarily pausing inoculations.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.